Format

Send to

Choose Destination
Immunity. 2018 Apr 17;48(4):623-625. doi: 10.1016/j.immuni.2018.03.036.

Inhibiting EBV: The Key to Carefree Smooching.

Author information

1
Duke-NUS Medical School, 8 College Road, Singapore 169857, and the Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, Singapore 117543, Singapore. Electronic address: sheemei.lok@duke-nus.edu.sg.

Abstract

There are no vaccines or therapies to treat Epstein-Barr virus (EBV). Snijder et al. (2018) isolated a potent human antibody against EBV that blocks infection of both B cells and epithelial cells. Structural analysis of the antibody complexed with a viral surface protein complex identified a site that may be useful in vaccine development.

PMID:
29669245
DOI:
10.1016/j.immuni.2018.03.036
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center